A CBD Research Partnership Fund has been launched by the Association québécoise de l’industrie du cannabis (AQIC) and the McGill Research Centre for Cannabis. Dr. Carolyn Baglole, Director of the McGill Research Centre for Cannabis, believes this increased research funding will result in increased safety and effectiveness of medical CBD.
“We are pleased to partner with the AQIC in a project that provides much-needed financial support for CBD research, the results of which ultimately will give a better understanding of the safety and efficacy of CBD. A partnership between McGill and the private sector will allow us to combine resources, thereby raising the bar of scientific discovery, and the promise that medical cannabis holds.”
Dr. Carolyn Baglole
The launch of this CBD Research Partnership Fund marks the second anniversary of the legalization of the use of cannabis in Canada.
Read the full article:
Advancing the Safety and Efficacy of Cannabidiol (CBD) for Medical Use AQIC and the McGill Research Centre for Cannabis Establish a CBD Research Partnership Fund. McGill’s Health e-News. Oct 19, 2020. Photo credit: Association québécoise de l’industrie du cannabis (AQIC)